# Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial

> **NCT05803538** · NA · UNKNOWN · sponsor: **Dilla University** · enrollment: 391 (estimated)

## Conditions studied

- Measles

## Interventions

- **DEVICE:** SMS, telephone interview or diary card

## Key facts

- **NCT ID:** NCT05803538
- **Lead sponsor:** Dilla University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-15
- **Primary completion:** 2023-12-20
- **Final completion:** 2024-01-30
- **Target enrollment:** 391 (ESTIMATED)
- **Last updated:** 2023-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05803538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05803538, "Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05803538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*